A team led by researchers from the Wellcome Sanger Institute has identified 145 key genes associated with DNA damage by systematically screening 997 genetically modified mouse lines. These findings offer new insights into cancer progression, neurodegenerative diseases, and introduce a potential therapeutic pathway through a protein inhibitor.

When the genome is stable, cells can accurately replicate and divide, passing on correct genetic information to the next generation of cells. Despite its significance, little is understood about the genetic factors governing genome stability, protection, repair, and the prevention of DNA damage. For this study, the team set out to better understand the biology of cellular health and identify genes key to maintaining genome stability. They used genetically modified mouse lines to pinpoint genes that influence the formation of abnormal micronuclei, indicators of genomic instability and DNA damage, which are prevalent in aging and various diseases.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The gene DSCC1 emerged as a critical player; its deletion led to a fivefold increase in abnormal micronuclei, mirroring symptoms of cohesinopathy disorders in humans. The study also explored therapeutic avenues, demonstrating that inhibiting the protein SIRT1 could partially reverse the effects of DSCC1 loss. This finding suggests that SIRT inhibitors could be a promising treatment strategy for cohesinopathies and other genomic disorders.

“Continued exploration on genomic instability is vital to develop tailored treatments that tackle the root genetic causes, with the goal of improving outcomes and the overall quality of life for individuals across various conditions. Our study underscores the potential of SIRT inhibitors as a therapeutic pathway for cohesinopathies and other genomic disorders. It suggests that early intervention, specifically targeting SIRT1, could help mitigate the biological changes linked to genomic instability before they progress,” explained Professor Gabriel Balmus, senior author of the study published in Nature.